The American Medical Association and others argue drugmakers need to be given incentives to manufacture medicines at risk of shortages.

Join The Ecosystem

Leave a Reply

Your email address will not be published. Required fields are marked

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}